COVID-19
Elon Musk-backed doctor critical of COVID response vows appeal after court sides with medical board

From LifeSiteNews
One of Gill’s “controversial” posts read, “If you have not yet figured out that we don’t need a vaccine, you are not paying attention. ”
A Canadian physician who challenged her medical regulator after it placed “cautions” against her for speaking out against draconian COVID mandates on social media has lost a court battle, but with the help of her Elon Musk-backed legal team she has vowed to appeal the ruling.
The case concerns Dr. Kulvinder Kaur Gill, an Ontario pediatrician who has been embroiled in a legal battle with the College of Physicians and Surgeons of Ontario (CPSO) for her anti-COVID views posted on X (formerly Twitter) in 2020. As reported by LifeSiteNews, her case received the support of billionaire Tesla and X owner Elon Musk, who pledged in March to back her financially.
One of Gill’s “controversial” posts read, “If you have not yet figured out that we don’t need a vaccine, you are not paying attention. #FactsNotFear.”
The Divisional Court decision against Gill dated May 7, 2024, concluded, “When the College chose to draw the line at those tweets which it found contained misinformation, it did so in a way which reasonably balanced Dr. Gill’s free speech rights with her professional responsibilities.”
“In other words, its response was proportionate,” noted the ruling.
Gill’s lawyer, Lisa Bildy with Libertas Law, stated in a press release sent to LifeSiteNews that the “Court declined to quash the ‘cautions’ orders, finding that the ‘screening committee’ of the CPSO was sufficiently alert to the Charter infringement of Dr. Gill’s speech, such that its decisions were within the range of reasonable outcomes.”
“Dr. Gill had argued, in two factums,” noted Bildy, which can be found here and here , and filed in the companion court applications, that “her statements were not ‘verifiably false.’”
Bildy expressed that Gill had provided the College with “ample evidence in 2020 to support her position against lockdowns,” but was sanctioned “because they went against the College’s guidance that doctors should not express opinions contradicting government or its public health edicts.”
Gill’s court challenge against the CPSO began last month, with Bildy writing at the time that the College’s “decisions were neither reasonable nor justified and they failed to engage with the central issues for which Dr. Gill was being cautioned.”
She argued that Gill had a “reasonable scientific basis” for her posts, noting that the previous decision made against Gill targeted her for opposing the mainstream COVID narrative.
“The decision starts with the premise that doctors have to comply,” said Bildy, warning that censoring doctors would have a “chilling effect” on free speech.
Bildy noted that in its ruling, the court “disagreed” with Gill’s challenge, “stating that this invited a reweighing of the evidence.”
The court also ordered that Gill pay the CPSO $6,000 in legal costs.
Gill is a specialist practicing in the Greater Toronto area, and has extensive experience and training in “pediatrics, and allergy and clinical immunology, including scientific research in microbiology, virology and vaccinology.”
Last September, disciplinary proceedings against her were withdrawn by the CPSO. However, last year, Gill was ordered to pay $1 million in legal costs after her libel suit was struck down.
The CPSO began disciplinary investigations against Gill in August 2020.
Gill to appeal recent court ruling with support from Musk’s X
The court’s ruling asserted that the CPSO panel members consisted of “three physicians with highly relevant expertise that they were able to bring to bear when assessing the scientific and medical information before them, expertise that this court does not have.”
Bildy noted that in fact, the CPSO panel consisted of “three surgeons and a general member of the public who had deferred to the ‘expertise’ of government’s public health arm.”
The court ruling also dismissed Gill’s arguments that publishing the “cautions on her public register and disseminating a notice about the cautions to hospitals and regulators across the continent was punitive and had a chilling effect on one side of a debate.”
“The Court opted to align with other Divisional Court decisions in stating that the cautions were not a finding of professional misconduct but were merely a remedial measure. This is despite the fact that cautions have, only in recent years, become a public rebuke rather than a private ‘correction’ of a professional by their peers. This significant change has not yet been grappled with by the Ontario Court of Appeal,” noted Bildy.
Bildy said that Gill intends to “seek leave to appeal to the Ontario Court of Appeal with the support of X Corp., since her posts were made on the X platform which supports free expression and dialogue, even on contentious issues and particularly on matters of scientific and medical importance.”
Gill noted on X Tuesday that her “notice of motion for leave to appeal will be filed” next week “to begin process.”
She also thanked Musk and X for supporting her legal cause.
Gill had said that she had “suddenly” found herself going “against the narrative,” and was then “seen as a black sheep and as someone who should be shunned.”
Many Canadian doctors who spoke out against COVID mandates and the experimental mRNA injections have been censured by their medical boards.
Earlier this month, Elon Musk’s X announced that it will fund the legal battle for another Canadian doctor critical of COVID lockdowns, Dr. Matthew Strauss, an Ontario critical care physician and professor, against his former employer Queen’s University after it forced him to resign.
In an interview with LifeSiteNews at its annual general meeting in July 2023 near Toronto, canceled doctors Mary O’Connor, Mark Trozzi, Chris Shoemaker, and Byram Bridle were asked to state their messages to the medical community regarding how they have had to fight censure because they have opinions contrary to the COVID mainstream narrative.
COVID-19
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

From LifeSiteNews
The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.
In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).
Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.
Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.
Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).
COVID-19
Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
-
International14 hours ago
Pentagon Salivates Over ‘Expensive’ Weapons While China Races Into Future With Iron Grip Over Cheap Drone Tech
-
Crime1 day ago
Canada Blocked DEA Request to Investigate Massive Toronto Carfentanil Seizure for Terror Links
-
Business23 hours ago
Top Canadian bank ditches UN-backed ‘net zero’ climate goals it helped create
-
2025 Federal Election2 days ago
The Liberals torched their own agenda just to cling to power
-
Alberta15 hours ago
Pierre Poilievre will run to represent Camrose, Stettler, Hanna, and Drumheller in Central Alberta by-election
-
Business2 days ago
Canada urgently needs a watchdog for government waste
-
Business2 days ago
Trump says he expects ‘great relationship’ with Carney, who ‘hated’ him less than Poilievre
-
COVID-1923 hours ago
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’